18 May 2017 | News
breatheriteTM also delivers a personal experience by profiling patients based on their attitudes towards Asthma management. breatheriteTM also delivers a personal experience by profiling patients based on their attitudes towards Asthma management.
Mundipharma recently launched the Asthma management app, breatheriteTM in Singapore as a part of their inaugural digital health initiative to deliver improved patient outcomes in response to unmet patient and doctor needs.
This free app available in Play store and iOS, utilizes augmented reality together with a range of smartphone sensors, to deliver a personal asthma management solution with a focus on correcting errors in inhaler technique. This app is currently available for downloading in Singapore and Philippines stores.
Like the popular social App, Snapchat, thebreatheriteTM App engages the front-facing camera for facial mapping, accelerometer and gyrometer to track inhaler preparation, the microphone to analyse inhalation and exhalation, along with augmented reality to visualise correct inhaler orientation and head alignment.
breatheriteTM also delivers a personal experience by profiling patients based on their attitudes towards Asthma management. Their symptoms and control measures are also tracked within the app. This information can be shared by the patient with their doctors to improve communication and better understand the patient’s condition while also helping to manage the day-to-day treatment of Asthma.
“The high rates of smartphone penetration across emerging markets and the inbuilt processing power of today’s mobile devices together with the increasing maturity of augmented reality technology have combined to create a real opportunity to tackle this decades old problem,” said Mundipharma CEO Raman Singh. “With World Asthma Day approaching, we are proud to launch this unparalleled new solution, which gives people with Asthma an opportunity to take greater control of their condition.”